Johnson & Johnson MedTech :: Smarter, Less Invasive & More Personalized Treatments for Complex Health Challenges

Johnson & Johnson MedTech (part of Johnson & Johnson) is a global leader in medical devices and technologies, focusing on advancing surgical care through innovation at the intersection of biology and technology. With a portfolio spanning Cardiovascular, Orthopaedics, Surgery, and Vision, J&J MedTech develops smarter, less invasive, and more personalized treatments for complex health challenges. The company has a long history of surgical innovation and is actively expanding its presence in robotic surgery and digital solutions to enhance precision, efficiency, and patient outcomes.

J&J MedTech is investing heavily in robotics to address unmet needs in general surgery, orthopaedics, and other specialties. Its robotic platforms aim to integrate seamlessly into existing workflows, reduce variability, and support surgeons with advanced visualization and control.

Key Robot-Based Products:

• OTTAVA™ Robotic Surgical System: J&J MedTech’s flagship general surgery robotic platform currently in advanced development. Designed with a unique unified architecture and integrated into the operating table, OTTAVA aims to reduce friction in the OR, improve ergonomics, and offer greater flexibility for a wide range of procedures. It recently completed first clinical cases and has an active IDE study. The system is built to support complex general surgery procedures with enhanced precision and control.
• VELYS™ Robotic-Assisted Solution: An orthopaedic robotics platform primarily used for total knee arthroplasty. It provides real-time data, precise bone resections, and personalized planning to improve implant positioning and patient outcomes.
• MONARCH™ Platform: Acquired through Auris Health, this flexible robotics system is used for bronchoscopy and lung procedures, enabling precise navigation in the airways for diagnosis and treatment.

J&J MedTech is also developing a broader digital surgery ecosystem (Polyphonic™) and partnering with companies like NVIDIA to accelerate robotics development using physical AI and digital twins. The company’s robotics strategy focuses on creating connected, adaptive systems that enhance surgical performance across multiple specialties while maintaining strong integration with its established portfolio of instruments and technologies (e.g., Ethicon).

Overall, Johnson & Johnson MedTech is transitioning from a traditional medtech leader into a more digitally enabled, robotics-focused organization, aiming to shape the future of surgery through innovation, clinical evidence, and ecosystem integration. (